Literature DB >> 116128

Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.

M T Scott, D Snary.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116128     DOI: 10.1038/282073a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptides.

Authors:  H J Zweerink; H D Weston; O F Andersen; S S Garber; E C Hayes
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

2.  Identification and characterization of a major surface antigen of Giardia lamblia.

Authors:  D A Einfeld; H H Stibbs
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

3.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.

Authors:  F G Araujo; B Morein
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.

Authors:  E E Jazín; A O Luquetti; A Rassi; A C Frasch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Trypanosoma cruzi: surface antigenic determinants.

Authors:  W M Tamashiro; D Repka; J K Sakurada; I J Camargo; P M Araújo; A M Atta; H A Rangel
Journal:  Z Parasitenkd       Date:  1983

7.  Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes.

Authors:  J González; M F Araguth; N Yoshida
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

8.  Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

9.  Monoclonal antibodies to Trypanosoma cruzi inhibit motility and nucleic acid synthesis of culture forms.

Authors:  M J Alves; M Aikawa; R S Nussenzweig
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Human and mouse sera recognize the same polypeptide associated with immunological resistance to Trypanosoma cruzi infection.

Authors:  M S Martins; L Hudson; A U Krettli; J R Cançado; Z Brener
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.